Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men

The Journal of Clinical Endocrinology and Metabolism
Matthias MöhligJoachim Spranger


Insulin resistance is a central feature of type 2 diabetes. Salicylates prevent lipid-induced insulin resistance in rodents by interrupting inflammatory pathways. We therefore investigated whether salicylates reduce lipid-induced insulin resistance in humans by affecting inflammatory pathways as reflected by serum adipocytokines. Ten healthy men were included in a crossover intervention study. Four euglycemic-hyperinsulinemic clamps were performed, one without pretreatment, one with prior 2-h lipid infusion, one after pretreatment with 4 g acetylsalicylic acid (ASA), and one with ASA pretreatment and prior lipid infusion. Lipid-induced insulin resistance was quantified by the euglycemic-hyperinsulinemic clamp technique running at least 2 h. Repeated-measures ANOVA on two factors was used for comparison, and results were Bonferroni adjusted for multiple measurements. ASA effects on serum adipocytokines were addressed by comparing the areas under the curves. Glucose infusion rate (M value) of the control clamp without pretreatment was 6.3 (+/- 0.6) mg/kg.min. ASA pretreatment did not change glucose infusion rates (P = 0.6). Lipid infusion significantly decreased the M value to 4.1 (+/- 0.6) mg/kg.min (P = 0.008). After ASA pretre...Continue Reading


Dec 1, 1983·The Journal of Clinical Endocrinology and Metabolism·W P Newman, R G Brodows
Oct 1, 1982·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·K P RatzmannB Schulz
Mar 16, 2001·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·G Boden
Aug 8, 2001·The Journal of Clinical Investigation·J K KimG I Shulman
May 8, 2002·The Journal of Clinical Endocrinology and Metabolism·Jean-Philippe BastardBernard Hainque
Aug 27, 2005·Diabetes·Thomas BobbertJoachim Spranger

❮ Previous
Next ❯


Jan 19, 2013·The Journal of Endocrinology·Sandra PereiraAdria Giacca
Jan 1, 2012·Scientifica·Martin O Weickert
Aug 28, 2007·Immunology Letters·Maximilian Zeyda, Thomas M Stulnig
Jun 23, 2011·Diabetes/metabolism Research and Reviews·Theodoros Thomas, Andreas F H Pfeiffer
May 30, 2012·Clinical Endocrinology·Martin O Weickert
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Camila ManriqueJames R Sowers
Jun 3, 2010·The Annals of Pharmacotherapy·Martha M Rumore, Katelynn S Kim
Jun 23, 2009·Nature Reviews. Endocrinology·Guido Lastra, Adam Whaley-Connell
Dec 7, 2007·The Journal of Clinical Endocrinology and Metabolism·Saskia N van der CrabbenHans P Sauerwein
Nov 14, 2013·Critical Reviews in Food Science and Nutrition·Wendy R RussellMartin O Weickert
Oct 17, 2008·Pharmacological Reviews·Nora Anderson, Jürgen Borlak
Apr 3, 2015·The Journal of Nutrition·Daniel J RaitenUNKNOWN INSPIRE Consultative Group
May 8, 2008·The Journal of Clinical Endocrinology and Metabolism·José-Manuel Fernández-RealWifredo Ricart
Jan 26, 2011·Expert Opinion on Therapeutic Targets·Niki KatsikiDimitrios Karamitsos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.